On Tuesday the 27th November, 17h30-18h30, Helen Tremlett will be giving a lecture on "Using population-based data linkage to investigate MS epidemiology: recent findings from British Columbia, Canada".
During her talk Helen will address the following questions:
The lecture will be held in the Clarke Kennedy Lecture Theatre, QMI Innovation Centre, Lower Ground Floor, 5 Walden Street, London E1 2EF. Click Here for a Map
- Are pregnancy outcomes worse for women with MS?
- What’s the cancer risk in MS?
- How does MS impact life expectancy?
- Do the beta-interferons impact long-term MS disease progression in clinical practice?
Helen Tremlett, is currently an associate professor at the University of British Columbia, Vancouver in the Faculty of Medicine, Division of Neurology and the Canada Research Chair in Neuroepidemiology and Multiple Sclerosis. Helen is also funded by the MS Society of Canada’s Don Paty Career Development Award and a Michael Smith Foundation for Health Research Scholar award. Also holds operating grants from CIHR, the US National MS Society and the UK MS Trust. Helen trained in pharmacoepidemiology/ multiple sclerosis with a PhD from Cardiff University, UK. She heads the ‘Pharmacoepidemiology in MS (PiMS) Research group. Her current research interests include: the natural history of MS; prognosis and predictors of disease progression in MS; effectiveness of the immunomodulatory drugs (IMDs) in MS; adverse effects of the MS IMDs; pharmacogenomics; MS epidemiology; cancer and MS; pregnancy outcomes and MS; impact of parental MS on childhood developmental outcomes; vitamin D, sunlight, infections and MS disease activity.
If you have an interest in MS you are welcome to attend please RSVP here: